COVID-19

Patient signing consent forms with nurse

May 5, 2022

FDA Updates on Paxlovid for Health Care Providers | SARS-CoV-2 Omicron Variant is as Deadly as Previous Waves After Adjusting for Vaccinations, Demographics, and Comorbidities | Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine

April 30, 2022

Children and COVID-19: State Date Report | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalization in the UK: a prospective observational study | Moderna files for authorization of Its COVID-19 Vaccine in young children six months to under six years of age | Public health impact of covid-19 vaccines in the US: observational study | FDA approves first COVID-19 Treatment for Young Children | Veru Announces Presentation of Phase 2 Data of Sabizabulin for the Treatment of Hospitalized Severe COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

Young black child getting a nose swab COVID-19 test

April 23, 2022

COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region | Hospitalizations of Children Aged 5–11 Years with confirmed COVID | SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses | Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children | Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster Vaccine | Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model | Intramuscular AZD7442 for Prevention of Covid-19

An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic

April 16, 2022

Children and COVID-19: State Date Report | Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance | Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination | Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization | Veru’s Novel COVID-19 Drug Candidate Reduces Deaths in Hospitalized Patients in Interim Analysis… | Comparison of Rapid Antigen Tests′ | SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies

people wearing face protection from infection of corona virus

April 9, 2022

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children | Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children | Protection by a Fourth Dose of BNT162b2 against Omicron in Israel | Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Ill blond senior woman sitting at home, taking oxygen from respirator while nurse sitting next to her and holding her hand.

April 2, 2022

Effect of Early Treatment with Ivermectin among Patients with COVID-19 | Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19A Randomized Clinical Trial | Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19 | Prone positioning of patients with moderate hypoxaemia due to covid-19: multicenter pragmatic randomized trial (COVID-PRONE) | U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals

Schoolkids disinfecting hands during coronavirus pandemic.

March 26, 2022

COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 | Intrinsic Severity of SARS-CoV-2 Omicron BA.2 in Uninfected, Unvaccinated Children: A Population-Based, Case-Control Study on Hospital Complications | SARS-CoV-2 Placentitis and Intraparenchymal Thrombohematomas Among COVID-19 Infections in Pregnancy | De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report

Four diverse male and female senior friends wearing face masks showing plasters after vaccination

March 19, 2022

Children and COVID19: State Level Data Report | Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 | Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022 | High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron | Comparison of Seroconversion in Children and Adults With Mild COVID-19

Two Medical Scientists in the Brain Research Laboratory

March 12, 2022

SARS-CoV-2 is associated with changes in brain structure | New Onset Dementia Among Survivors of Pneumonia Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection | Whole genome sequencing reveals host factors underlying critical Covid-19 | Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality | Pfizer Initiated a Phase 2/3 Study of their Novel COVID-19 Oral Treatment in Pediatric Participants | Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

Doctor nurse in protective face mask listening to breath with a stethoscope suspecting Coronavirus

March 5, 2022

Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID | Development and validation of SCOPE score: a clinical score to predict progression of COVID-19 pneumonia to severe respiratory failure | Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant | Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top